These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8152798)

  • 1. Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.
    Zhu G; Decker SJ; Maclean D; McNamara DJ; Singh J; Sawyer TK; Saltiel AR
    Oncogene; 1994 May; 9(5):1379-85. PubMed ID: 8152798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of interactions between epidermal growth factor receptor and SH2 domain proteins.
    Sierke SL; Longo GM; Koland JG
    Biochem Biophys Res Commun; 1993 Feb; 191(1):45-54. PubMed ID: 7680558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
    MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
    Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine kinase-substrate interactions.
    Bose R; Holbert MA; Pickin KA; Cole PA
    Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor.
    Zhu G; Decker SJ; Mayer BJ; Saltiel AR
    J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
    Charest A; Wagner J; Kwan M; Tremblay ML
    Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cloning of Grb10 reveals a new family of SH2 domain proteins.
    Ooi J; Yajnik V; Immanuel D; Gordon M; Moskow JJ; Buchberg AM; Margolis B
    Oncogene; 1995 Apr; 10(8):1621-30. PubMed ID: 7731717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.